December 31, 2020
January 26, 2021
This newsletter covers holiday greetings from BioUtah, and topics such as Phoenix Pharmalabs announcing a new investment offering with Netcapital, Co-Diagnostics announcing its test to identify certain Coronavirus strain mutations, the Utah COVID-19 Business Manual to prevent the spread of Covid-19, and more.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
